Literature DB >> 19767091

Progress in primary CNS lymphoma.

Peter C O'Brien1, John F Seymour.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19767091     DOI： 10.1016/S0140-6736(09)61488-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Clinical relevance of the dose of cytarabine in the upfront treatment of primary CNS lymphomas with methotrexate-cytarabine combination.

Authors:  Andrés J M Ferreri; Giada Licata; Marco Foppoli; Gaetano Corazzelli; Emanuele Zucca; Caterina Stelitano; Francesco Zaja; Sergio Fava; Rossella Paolini; Alberto Franzin; Letterio S Politi; Maurilio Ponzoni; Michele Reni
Journal:  Oncologist       Date:  2011-02-23

2.  Age, gender, and racial differences in incidence and survival in primary CNS lymphoma.

Authors:  J L Villano; M Koshy; H Shaikh; T A Dolecek; B J McCarthy
Journal:  Br J Cancer       Date:  2011-09-13       Impact factor: 7.640

3.  Primary central nervous system lymphoma mimicking recurrent depressive disorder: A case report.

Authors:  Weibo Liu; Jing Xue; Shaohua Yu; Qiaozhen Chen; Xiuzhen Li; Risheng Yu
Journal:  Oncol Lett       Date:  2015-02-13       Impact factor: 2.967
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.